M D Griffin
Overview
Explore the profile of M D Griffin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1086
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ryan C, Pugliese E, Shologu N, Gaspar D, Rooney P, Islam M, et al.
Mater Today Bio
. 2021 Oct;
12:100130.
PMID: 34632361
During culture, bereft of their optimal tissue context, tenocytes lose their phenotype and function. Considering that tenocytes in their native tissue milieu are exposed simultaneously to manifold signals, combination approaches...
2.
Liew A, Baustian C, Thomas D, Vaughan E, Sanz-Nogues C, Creane M, et al.
Cell Transplant
. 2018 Jul;
27(8):1210-1221.
PMID: 30016879
Intramuscular administration of mesenchymal stromal cells (MSCs) represents a therapeutic option for diabetic critical limb ischemia. Autologous or allogeneic approaches may be used but disease-induced cell dysfunction may limit therapeutic...
3.
Raymakers A, Gillespie P, OHara M, Griffin M, Dinneen S
Health Qual Life Outcomes
. 2018 Feb;
16(1):27.
PMID: 29394942
Aims: Generic, preference-based measures of health-related quality of life (HRQoL) are a common input to the economic evaluation of new health technologies. As such, it is important to explore what...
4.
ANCA-associated vasculitis: a comparison of cases presenting to nephrology and rheumatology services
McNicholas B, Griffin T, Donnellan S, Ryan L, Garrahy A, Coughlan R, et al.
QJM
. 2016 Jun;
109(12):803-809.
PMID: 27318367
Background: Anti-neutrophil cytoplasmic antibody (ANCA) -associated vasculitis (AAV) is a disease characterized by inflammation of small vessels and detectable ANCA in the circulation. Patients may develop a broad spectrum of...
5.
Lohan P, Treacy O, Lynch K, Barry F, Murphy M, Griffin M, et al.
Osteoarthritis Cartilage
. 2015 Oct;
24(3):521-33.
PMID: 26493330
Objective: Allogeneic cell therapies, such as mesenchymal stromal cells (MSC), which have potent regenerative and anti-inflammatory potential are being investigated as a therapy for osteoarthritis (OA) and cartilage injury. Here...
6.
Treacy O, OFlynn L, Ryan A, Morcos M, Lohan P, Schu S, et al.
Am J Transplant
. 2014 Oct;
14(9):2023-36.
PMID: 25307035
Mesenchymal stem cells (MSCs) are being investigated extensively due to their ability to dampen immune responses. Here, we tested the ability of MSCs from three distinct sources to prolong rat...
7.
Amer H, Griffin M, Stegall M, Cosio F, Park W, Kremers W, et al.
Am J Transplant
. 2013 Apr;
13(6):1576-85.
PMID: 23601186
Postkidney transplant hyperparathyroidism is a significant problem. Vitamin D receptor agonists are known to suppress parathyroid hormone (PTH) secretion. We examined the effect of oral paricalcitol on posttransplant secondary hyperparathyroidism...
8.
Leung N, Shaikh A, Cosio F, Griffin M, Textor S, Gloor J, et al.
Am J Transplant
. 2010 Jan;
10(3):558-62.
PMID: 20055804
Nephrogenic systemic fibrosis (NSF) is a debilitating disease in patients with severely diminished kidney function. Currently, no standard treatment exists but improvement has been reported after restoration of kidney function....
9.
Issa N, Amer H, Dean P, Kremers W, Kudva Y, Rostambeigi N, et al.
Am J Transplant
. 2009 Jun;
9(8):1894-902.
PMID: 19519812
The incidence, risk factors and impact on patient and graft survival were evaluated for posttransplant lymphoproliferative disorder (PTLD) among 212 pancreas transplant recipients. Thirteen (6.1%) developed PTLD during 71 +/-...
10.
Leung N, Gloor J, Dean P, Lacy M, Porrata L, Griffin M
Bone Marrow Transplant
. 2008 Oct;
43(4):345-6.
PMID: 18850016
No abstract available.